Myriam Anne Armant, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Scleral Diseases | 1 | 2022 | 22 | 0.800 |
Why?
|
Limbus Corneae | 2 | 2022 | 145 | 0.790 |
Why?
|
Epithelium, Corneal | 2 | 2022 | 254 | 0.730 |
Why?
|
Corneal Diseases | 1 | 2022 | 539 | 0.520 |
Why?
|
Interleukin-12 | 6 | 1999 | 578 | 0.350 |
Why?
|
Anemia, Sickle Cell | 3 | 2023 | 1065 | 0.310 |
Why?
|
Lentivirus | 3 | 2024 | 519 | 0.300 |
Why?
|
Hematopoietic Stem Cell Mobilization | 2 | 2019 | 225 | 0.300 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 2 | 2018 | 24 | 0.280 |
Why?
|
Receptors, IgE | 3 | 1999 | 375 | 0.250 |
Why?
|
Cell Transplantation | 2 | 2022 | 475 | 0.240 |
Why?
|
Interferon-gamma | 5 | 1999 | 3169 | 0.230 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2024 | 147 | 0.220 |
Why?
|
GATA1 Transcription Factor | 1 | 2024 | 307 | 0.220 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 113 | 0.210 |
Why?
|
Transplantation, Autologous | 4 | 2022 | 2126 | 0.210 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2023 | 131 | 0.210 |
Why?
|
Genetic Vectors | 5 | 2024 | 3417 | 0.210 |
Why?
|
Amniotic Fluid | 3 | 2011 | 381 | 0.200 |
Why?
|
Hydroxyurea | 1 | 2023 | 284 | 0.200 |
Why?
|
T-Lymphocytes | 8 | 2024 | 10273 | 0.190 |
Why?
|
Fetal Hemoglobin | 2 | 2023 | 346 | 0.190 |
Why?
|
Hematopoietic Stem Cells | 7 | 2024 | 3408 | 0.190 |
Why?
|
Eczema | 1 | 2023 | 246 | 0.180 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2019 | 263 | 0.180 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2022 | 350 | 0.180 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 115 | 0.170 |
Why?
|
gamma-Globins | 1 | 2020 | 105 | 0.170 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 305 | 0.170 |
Why?
|
Fanconi Anemia | 1 | 2022 | 327 | 0.170 |
Why?
|
Membrane Glycoproteins | 3 | 2002 | 3713 | 0.160 |
Why?
|
Multigene Family | 1 | 2002 | 1081 | 0.160 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2020 | 175 | 0.160 |
Why?
|
Interleukin-2 | 2 | 1996 | 1894 | 0.160 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
Chromosomes, Human, X | 1 | 2020 | 321 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 4 | 2017 | 1671 | 0.150 |
Why?
|
Antigens, CD | 4 | 2024 | 4029 | 0.150 |
Why?
|
Blood Component Removal | 1 | 2018 | 132 | 0.140 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.140 |
Why?
|
Monokines | 2 | 1999 | 71 | 0.140 |
Why?
|
Graft Survival | 3 | 2019 | 3890 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 662 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 462 | 0.140 |
Why?
|
Cells, Cultured | 10 | 2022 | 19041 | 0.140 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2017 | 568 | 0.130 |
Why?
|
Hydroxamic Acids | 1 | 2019 | 482 | 0.130 |
Why?
|
Down-Regulation | 3 | 2020 | 2944 | 0.130 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1505 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 620 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 325 | 0.130 |
Why?
|
Monocytes | 4 | 1999 | 2591 | 0.130 |
Why?
|
Rabbits | 1 | 2022 | 4786 | 0.130 |
Why?
|
Neutropenia | 1 | 2021 | 892 | 0.130 |
Why?
|
Adrenoleukodystrophy | 1 | 2017 | 144 | 0.120 |
Why?
|
Gammaretrovirus | 1 | 2014 | 24 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 2 | 1999 | 1855 | 0.120 |
Why?
|
Interleukin-7 | 1 | 1995 | 144 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2024 | 5709 | 0.120 |
Why?
|
Tissue Engineering | 3 | 2011 | 1890 | 0.120 |
Why?
|
Metformin | 1 | 2022 | 914 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1797 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1265 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2019 | 776 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 630 | 0.110 |
Why?
|
16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.110 |
Why?
|
Antigens, CD34 | 4 | 2020 | 656 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1036 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2022 | 1602 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2023 | 3697 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 1998 | 2568 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1712 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2002 | 2819 | 0.100 |
Why?
|
Carrier Proteins | 3 | 1999 | 4948 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2832 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1669 | 0.100 |
Why?
|
Apoptosis | 5 | 2014 | 9526 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 649 | 0.090 |
Why?
|
Flow Cytometry | 5 | 2014 | 5904 | 0.090 |
Why?
|
Galectin 1 | 1 | 2011 | 128 | 0.090 |
Why?
|
Regenerative Medicine | 1 | 2013 | 311 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2987 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 2012 | 437 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 1995 | 1561 | 0.080 |
Why?
|
Research Support as Topic | 1 | 2014 | 699 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 178 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2415 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 2011 | 530 | 0.080 |
Why?
|
Diaphragm | 1 | 2011 | 360 | 0.080 |
Why?
|
Fetal Blood | 2 | 2013 | 1353 | 0.080 |
Why?
|
Humans | 44 | 2024 | 768451 | 0.080 |
Why?
|
Dinoprostone | 1 | 2011 | 597 | 0.080 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1905 | 0.070 |
Why?
|
Program Development | 1 | 2014 | 1296 | 0.070 |
Why?
|
Lymphoproliferative Disorders | 1 | 2011 | 531 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 3437 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2929 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2011 | 1797 | 0.070 |
Why?
|
Tendons | 1 | 2011 | 559 | 0.070 |
Why?
|
Bioprosthesis | 1 | 2011 | 592 | 0.070 |
Why?
|
Animals | 15 | 2024 | 169418 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 1995 | 2209 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1924 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2011 | 507 | 0.060 |
Why?
|
Mice | 8 | 2024 | 82045 | 0.060 |
Why?
|
Dendritic Cells | 3 | 2010 | 2757 | 0.060 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1081 | 0.060 |
Why?
|
Antigens, CD7 | 1 | 2024 | 29 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7471 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 1995 | 5495 | 0.060 |
Why?
|
Models, Animal | 1 | 2011 | 2126 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2018 | 808 | 0.060 |
Why?
|
Cryopreservation | 3 | 2017 | 731 | 0.060 |
Why?
|
Transcription Factors | 2 | 2023 | 12174 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9507 | 0.050 |
Why?
|
HIV | 1 | 2010 | 1596 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1994 | 4362 | 0.050 |
Why?
|
Cytokines | 4 | 2021 | 7449 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2023 | 163 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11930 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 1409 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 1995 | 4534 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2485 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1869 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 115 | 0.050 |
Why?
|
Fibroblasts | 1 | 2012 | 4180 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2022 | 267 | 0.050 |
Why?
|
Colony-Forming Units Assay | 2 | 2012 | 352 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2023 | 2058 | 0.050 |
Why?
|
Gene Silencing | 2 | 2020 | 1503 | 0.050 |
Why?
|
Erythropoiesis | 1 | 2024 | 694 | 0.040 |
Why?
|
Mitochondria | 1 | 2014 | 3672 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1672 | 0.040 |
Why?
|
Chromones | 1 | 1999 | 148 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6816 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18048 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1999 | 48 | 0.040 |
Why?
|
Thrombospondins | 1 | 1999 | 195 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2020 | 373 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2002 | 582 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8051 | 0.040 |
Why?
|
Immune Tolerance | 2 | 1998 | 2326 | 0.040 |
Why?
|
CD40 Ligand | 2 | 1998 | 524 | 0.040 |
Why?
|
Complementarity Determining Regions | 1 | 2018 | 150 | 0.040 |
Why?
|
Commerce | 1 | 2023 | 613 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1999 | 447 | 0.040 |
Why?
|
Androstadienes | 1 | 1999 | 348 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23638 | 0.040 |
Why?
|
Interleukin-15 | 1 | 1998 | 185 | 0.040 |
Why?
|
Child | 6 | 2022 | 80863 | 0.040 |
Why?
|
Amniocentesis | 2 | 2008 | 116 | 0.040 |
Why?
|
Benzylamines | 1 | 2018 | 252 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 213 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2216 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1303 | 0.030 |
Why?
|
Caspases | 1 | 1999 | 884 | 0.030 |
Why?
|
Cell Division | 2 | 2018 | 4479 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 2003 | 0.030 |
Why?
|
Morpholines | 1 | 1999 | 583 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2023 | 5308 | 0.030 |
Why?
|
Pilot Projects | 2 | 2020 | 8730 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1608 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1883 | 0.030 |
Why?
|
Interphase | 1 | 1996 | 227 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2846 | 0.030 |
Why?
|
Enterotoxins | 1 | 1997 | 366 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1839 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 89 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 631 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22386 | 0.030 |
Why?
|
United States Food and Drug Administration | 2 | 2014 | 1669 | 0.030 |
Why?
|
Erythrocytes | 1 | 2023 | 2422 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2633 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1193 | 0.030 |
Why?
|
Forms and Records Control | 1 | 2014 | 158 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 1995 | 607 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 60045 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 1997 | 965 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1998 | 998 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2012 | 1343 | 0.030 |
Why?
|
Keratin-3 | 1 | 2012 | 4 | 0.030 |
Why?
|
Ligands | 2 | 1998 | 3281 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2020 | 1598 | 0.030 |
Why?
|
Child, Preschool | 3 | 2021 | 42623 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1465 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2014 | 10494 | 0.020 |
Why?
|
Cell Separation | 2 | 2008 | 1726 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8510 | 0.020 |
Why?
|
Adult | 7 | 2024 | 223542 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1062 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 903 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2012 | 290 | 0.020 |
Why?
|
Mutation | 3 | 2023 | 30243 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 371 | 0.020 |
Why?
|
Cell Communication | 1 | 1998 | 1662 | 0.020 |
Why?
|
Amnion | 1 | 2012 | 202 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2014 | 1992 | 0.020 |
Why?
|
Dermis | 1 | 2012 | 204 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1015 | 0.020 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9263 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1086 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2013 | 594 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 89168 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1994 | 1251 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 12813 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1892 | 0.020 |
Why?
|
Osteogenesis | 1 | 2017 | 1296 | 0.020 |
Why?
|
United States | 5 | 2020 | 73121 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 225 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2010 | 209 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 463 | 0.020 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 244 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2011 | 245 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2011 | 193 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 868 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2014 | 1083 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2011 | 321 | 0.020 |
Why?
|
Male | 7 | 2024 | 364781 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3734 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1997 | 1461 | 0.020 |
Why?
|
Gestational Age | 2 | 2008 | 3615 | 0.020 |
Why?
|
Primates | 1 | 2011 | 523 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5803 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1999 | 1644 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6091 | 0.020 |
Why?
|
Sheep | 1 | 2011 | 1451 | 0.020 |
Why?
|
Phagocytosis | 1 | 2014 | 1531 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2328 | 0.020 |
Why?
|
Female | 8 | 2024 | 396943 | 0.020 |
Why?
|
Protein Binding | 1 | 1999 | 9376 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1888 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3790 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 657 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9558 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2996 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7134 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10784 | 0.020 |
Why?
|
Serum | 1 | 2007 | 208 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1998 | 4419 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4520 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8559 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2010 | 833 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3329 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 65409 | 0.020 |
Why?
|
Culture Media | 1 | 2007 | 899 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10601 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4834 | 0.010 |
Why?
|
Interleukin-6 | 1 | 1994 | 3234 | 0.010 |
Why?
|
Cell Line | 2 | 2014 | 15609 | 0.010 |
Why?
|
Electroencephalography | 1 | 2019 | 6309 | 0.010 |
Why?
|
Specimen Handling | 1 | 2008 | 709 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4586 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5042 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2422 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2393 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3123 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4138 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7605 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1395 | 0.010 |
Why?
|
Cattle | 1 | 2007 | 3830 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3611 | 0.010 |
Why?
|
Integrin alphaV | 1 | 1999 | 54 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3463 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8081 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5797 | 0.010 |
Why?
|
Aged | 3 | 2024 | 171520 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5801 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2010 | 5152 | 0.010 |
Why?
|
Pregnancy | 2 | 2011 | 30179 | 0.010 |
Why?
|
Solubility | 1 | 1999 | 1086 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223418 | 0.010 |
Why?
|
Mitogens | 1 | 1997 | 229 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7895 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1379 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8635 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17149 | 0.010 |
Why?
|
Interleukin-10 | 1 | 1998 | 1185 | 0.010 |
Why?
|
Antigens | 1 | 1998 | 1443 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14728 | 0.010 |
Why?
|
Cell Count | 1 | 1997 | 1835 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36497 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18388 | 0.010 |
Why?
|
Spleen | 1 | 1997 | 2298 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1998 | 2003 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16712 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6241 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7599 | 0.000 |
Why?
|
HIV Infections | 1 | 2010 | 17564 | 0.000 |
Why?
|